|
1.
|
RT GreenleeT MurrayS BoldenPA WingoCancer
StatisticsCA Cancer J Clin507332000
|
|
2.
|
J LiDJ MinnichER CampA BrankSL MackaySN
HochwaldEnhanced sensitivity to chemotherapy in esophageal cancer
through inhibition of NF-κBJ Surg Res1321121202006
|
|
3.
|
CT LeeJY SeolSY LeeThe effect of
adenovirus-Ikappa Balpha transduction on the chemosensitivity of
lung cancer cell line with resistance to
cis-diaminedichloroplatinum (II) (cisplatin) and doxorubicin
(adriamycin)Lung
Cancer41199206200310.1016/S0169-5002(03)00227-712871783
|
|
4.
|
HJ ShimSH ChoJE HwangPhase II study of
docetaxel and cisplatin chemotherapy in 5-f luorouracil/cisplatin
pretreated esophageal cancerAm J Clin
Oncol33624628201010.1097/COC.0b013e3181bead9220142726
|
|
5.
|
C FriesenI HerrPH KrammerKM
DebatinInvolvement of the CD95 (APO-1/FAS) receptor/ligand system
in drug-induced apoptosis in leukemia cellsNat
Med2574577199610.1038/nm0596-5748616718
|
|
6.
|
S FuldaSA SusinG KroemerKM
DebatinMolecular ordering of apoptosis induced by anticancer drugs
in neuroblastoma cellsCancer Res584453446019989766678
|
|
7.
|
DE FisherApoptosis in cancer therapy:
crossing the
thresholdCell78539542199410.1016/0092-8674(94)90518-58069905
|
|
8.
|
J LotemL SachsRegulation by bcl-2, c-myc,
and p53 of susceptibility to induction of apoptosis by heat shock
and cancer chemotherapy compounds in differentiation-competent and
-defective myeloid leukemic cellsCell Growth Differ441471993
|
|
9.
|
CY WangMW MayoRG KornelukDV GoeddelAS
Baldwin JrNF-κB antiapoptosis: induction of TRAF1 and TRAF2 and
c-IAP1 and c-IAP2 to suppress caspase-8
activationScience281168016831998
|
|
10.
|
CY WangMW MayoAS Baldwin JrTNF- and cancer
therapy-induced apoptosis: potentiation by inhibition of
NF-κBScience27478478719968864119
|
|
11.
|
R VoborilSN HochwaldJ LiA BrankJ WeberovaF
WesselsLL MoldawerER CampSL MacKayInhibition of NF-kappa B augments
sensitivity to 5-fluorouracil/folinic acid in colon cancerJ Surg
Res120178188200410.1016/j.jss.2003.11.02315234211
|
|
12.
|
JC Cusack JrR LiuM HoustonEnhanced
chemosensitivity to CPT-11 with proteasome inhibitor PS-341:
implications for systemic nuclear factor-κB inhibitionCancer
Res6135353540200111325813
|
|
13.
|
MG HertogPC HollmanMB KatanD
KromhoutIntake of potentially anticarcinogenic flavonoids and their
determinants in adults in the NetherlandsNutr
Cancer202129199310.1080/016355893095142678415127
|
|
14.
|
B CsokayN PrajdaG WeberE OlahMolecular
mechanisms in the antiprolife- rative action of quercetinLife
Sci6021572163199710.1016/S0024-3205(97)00230-09188758
|
|
15.
|
F CasagrandeJM DarbonEffects of
structurally related flavonoids on cell cycle progression of human
melanoma cells: regulation of cyclin-dependent kinases CDK2 and
CDK1Biochem
Pharmacol6112051215200110.1016/S0006-2952(01)00583-411322924
|
|
16.
|
TT NguyenE TranTH NguyenPT DoTH HuynhH
HuynhThe role of activated MEK-ERK pathway in quercetin-induced
growth inhibition and apoptosis in A549 lung cancer
cellsCarcinogenesis25647659200410.1093/carcin/bgh05214688022
|
|
17.
|
K KawadaT YoneiH UeokaComparison of
chemosensitivity tests: clonogenic assay versus MTT assayActa Med
Okayama56129134200212108583
|
|
18.
|
MH LamQ LiuSJ ElledgeJM RosenChk1 is
haploinsufficient for multiple functions critical to tumor
suppressionCancer
Cell64559200410.1016/j.ccr.2004.06.01515261141
|
|
19.
|
Y YamamuraWL LeeMX GohY ItoRole of
TAp73alpha in induction of apoptosis by transforming growth
factor-beta in gastric cancer cellsFEBS
Lett58226632667200810.1016/j.febslet.2008.06.04618593586
|
|
20.
|
M KurokawaC ZhaoT ReyaS
KornbluthInhibition of apoptosome formation by suppression of
Hsp90beta phosphorylation in tyrosine kinase-induced leukemiasMol
Cell Biol2854945506200810.1128/MCB.00265-0818591256
|
|
21.
|
D HanahanRA WeinbergThe hallmarks of
cancerCell1005770200010.1016/S0092-8674(00)81683-9
|
|
22.
|
KC ZimmermannDR GreenHow cells die:
apoptosis pathwaysJ Allergy Clin Immunol108Suppl
499103200110.1067/mai.2001.11781911586274
|
|
23.
|
F ChenK BeezholdV CastranovaTumor
promoting or tumor suppressing of NF-kappa B, a matter of cell
context dependencyInt Rev
Immunol27183204200810.1080/0883018080213032718574736
|
|
24.
|
C JobinA PanjaC HellerbrandInhibition of
proinflammatory molecule production by adenovirus-mediated
expression of a nuclear factor kappaB super-repressor in human
intestinal epithelial cellsJ Immunol1604104181998
|
|
25.
|
M HinzP LoserS MathasD KrappmannB DorkenC
ScheidereitConstitutive NF-kappaB maintains high expression of a
characteristic gene network, including CD40, CD86, and a set of
antiapoptotic genes in Hodgkin/Reed-Sternberg
cellsBlood9727982807200110.1182/blood.V97.9.279811313274
|
|
26.
|
S HuangCA PettawayH UeharaCD BucanaIJ
FidlerBlockade of NF-kappaB activity in human prostate cancer cells
is associated with suppression of angiogenesis, invasion, and
metastasisOncogene2041884197200110.1038/sj.onc.120453511464285
|
|
27.
|
X BianAW Opipari JrAB
RatanaproeksaConstitutively active NFkappa B is required for the
survival of S-type neuroblastomaJ Biol
Chem2774214442150200210.1074/jbc.M20389120012198114
|
